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Abstract
BACKGROUND: Sepsis is a major challenge in emergency departments and intensive care units (ICUs). Sepsis also 
mimics or interacts with many other disorders causing high mortality and morbidity. There is no accurate biomarker or 
test to diagnose or predict sepsis. The treatment of sepsis is often based on the clinician’s experience. 
AIM: We conducted this study to analyze the serum level of presepsin in pediatric critical patients with SIRS, sepsis, 
severe sepsis, and septic shock.
METHODS: The study included 58 children, 32 septic pediatric patients admitted to the Pediatric ICU (PICU) of Cairo 
University Teaching Hospital and 26 healthy children who served as a control group. The aim was to estimate the 
diagnostic accuracy of presepsin in predicting sepsis in PICU. We classified the patients into systemic inflammatory 
response syndrome, sepsis, severe sepsis, and septic shock according to the international consensus conference criteria.
RESULTS: In our study, we detected a positive correlation between C-reactive protein and presepsin levels at day 
1 and day 3 of admission and a negative correlation between hemoglobin and presepsin levels at day 1. However, 
we found no difference in the serum presepsin between the children who had sepsis and the healthy ones (at day 1 
[p = 0.430) and at day 3 [p = 0.845]). We also found that serum levels of presepsin were not significantly increased 
with the increasing severity of sepsis despite the higher median values with increasing sepsis severity.
CONCLUSIONS: It was noted that presepsin levels increased in anemic critical patients, whereas presepsin had no 
role in differentiating the septic critical patients from healthy children. However, its level increased with increasing 
severity of sepsis grade.
Introduction
Sepsis is a type of systemic inflammatory 
response syndrome (SIRS) caused by the invasion of 
pathogens or conditional pathogenic bacteria into the 
blood circulation. It can develop into severe sepsis, 
septic shock, and multiple organ failure [1].
Sepsis is the most common cause of death in 
infants and children worldwide. Lack of reporting and 
the fact that sepsis mimics or interacts with many other 
disorders make estimating the burden of sepsis difficult. 
However, in industrialized countries, the overall mortality 
rate of children with severe sepsis and septic shock is 
estimated between 2 and 10%, whereas mortality in 
developing countries is reported as high as 50% [2].
The majority of sepsis cases and deaths 
are estimated to occur in low and middle-income 
countries [3]. In 2017, there were an estimated 
23.7 million (20.1–28.8) incident sepsis cases among 
adults 20 years and older [4].
Early diagnosis and timely intervention 
are essential to improve the prognosis of septic 
patients. Bacterial culture is generally regarded as 
the gold standard for the diagnosis of sepsis, but it 
is time-consuming, frequently yields false-negative 
results, and microbial contamination can greatly affect 
its diagnostic value. Thus, the treatment of sepsis is 
often based on the clinician’s experience, which risks 
an increase in antibiotic resistance and the cost of 
medical care. It is, therefore, necessary and urgent to 
develop a rapid and accurate method for the diagnosis 
of sepsis [5]. Anti-microbial resistance may be a major 
driver of the global burden of both community and 
hospital-acquired sepsis. More than 700,000 deaths/
year may be attributable to anti-microbial resistance 
infections globally [3]. About 76% of the patients 
who were admitted to Indian Pediatric Intensive Care 
Units (PICU) received more than two antibiotics 
simultaneously. The antibiotic policy may aid in the 
development of anti-microbial resistance [6]. A study 
from Kazakhstan reporting high prevalence of antibiotic 
resistance in the intensive care units (ICU) [7].
Various biomarkers have been reported 
useful in sepsis diagnosis such as pro-calcitonin and 
C-reactive protein (CRP). However, these biomarkers 
may also be elevated in non-septic conditions such 
as trauma, burns, and post-operative settings and 
some are slow to rise after the onset of sepsis. It, thus, 
remains necessary to find reliable biomarkers to replace 
or improve those that are currently available [5].
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Recent systematic reviews reported that 
presepsin had high sensitivity and specificity in predicting 
sepsis in neonates [8], [9], [10]. It was reported that 
presepsin levels peak at 3h after the onset of infection. 
Serum presepsin can be measured easily and rapidly [11]. 
Therefore, presepsin could be a useful biomarker for the 
early diagnosis of sepsis [12]. Pediatrics studies about 
presepsin are few. We conducted this study to analyze 
the serum level of presepsin in pediatric critical patients 
with SIRS, sepsis, severe sepsis, and septic shock.
Patients and Methods
Settings
This study was carried out in the PICU of the 
main children hospital of Cairo University, Egypt, in the 
period between April 2016 and December 2017.
Patients
Fifty-eight children were enrolled in this study 
and were divided them into two groups: Group I: 
32 septic critical pediatric patients and Group II: 26 
healthy children who served as a control group from the 
outpatient clinic coming for elective surgical procedures 
who were age- and sex-matched. Inclusion criteria were 
the presence of sepsis, severe sepsis, or septic shock 
according to the international consensus conference 
criteria and three post-operative patients with suspected 
SIRS according to the international consensus 
conference criteria [13]. Exclusion criteria were those 
suffering from renal impairment. All the patients in this 
study received the ethical committee approval and 
informed consent was taken from the parents.
Data collection
The data collection was sequential organ failure 
assessment score [14], Glasgow coma scale, complete 
blood picture, liver and kidney function tests, coagulation 
profile, CRP, blood culture, and blood gases.
Sampling
Five milliliters of venous blood were withdrawn 
from each subject under complete aseptic conditions. 
Presepsin concentration was measured using a 
commercially available ELISA kit supplied by Bioneovan 
Co., China. Assay range was 65 pg/ml–3000 pg/ml.
Statistical analysis
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 23. Data were summarized 
using median, minimum, and maximum in quantitative 
data and using frequency (count) and relative frequency 
(percentage) for categorical data. Comparisons 
between quantitative variables were done using the 
non-parametric Kruskal–Wallis and Mann–Whitney 
tests [15]. Correlations between quantitative variables 
were done using Spearman correlation coefficient [16]. 
p < 0.05 was considered as statistically significant.
Results
Patients were divided into two groups: Group I: 
32 septic pediatric patients, Group II: 26 healthy 
children, 17 (53.1%) males and 15 (46.9%) females, 
their age ranged from 2 months to 12 years. As regards 
the sepsis classification, 3 patients (9.4%) had SIRS, 
10 (31.2%) had sepsis, 12 (37.5%) had severe sepsis, 
and 7 (21.9%) had septic shock. The most common 
cause of ICU admission was a respiratory failure 
(31.3%) followed by septic shock (21.9%). About 21% 
of the patients were mechanically ventilated (Table 1).
Table 1: The clinical characteristics of studied patients
Clinical data of the study group Frequency and %
Age median and range (1.5 years) 2 months–11 years
No. (%)
Sex
Males 17 (53.1)
Females 15 (46.9)
Diagnosis
Respiratory failure 10 (31.3)
Septic shock (blood born) 7 (21.9)
Central nervous system infection 4 (12.5)
Post-operative (intestinal obstruction) 4 (12.5)
Other* 3 (9.4)
Gastroenteritis 2 (6.2)
Heart failure 2(6.2)
Grades of sepsis
SIRS* 3 (9.4)
Sepsis 10 (31.2)
Severe sepsis 12 (37.5)
Septic shock 7 (21.9)
GCS*(median and range) 12(3–15)
SOFA score** 5 (0–14)
Mechanical ventilation no and %
9 28.1%
Laboratory characteristics Median (Min-Max)
Hb (g/dL)** 10.3 (7.6–15.7)
CRP (mg/L)** 48 (28–184)
PT (s)** 15.95 (10.70–37.90)
ALT (U/L)** 46.50 (14–972)
Creatinine (mg/dL) 0.50 (0.20–3.20)
*Others (toxin ingestion and infected hematoma in a hemophilia patient); **SOFA: Sequential organ 
failure assessment, Hb: Hemoglobin, CRP: C-reactive protein, PT: Prothrombin time, ALT: Alanine 
aminotransferase. 
Table 2: Comparison of presepsin levels between septic 
patients and healthy children at day 1 and day 3 of admission
Presepsin at day 
1 and 3
Patients Controls P value
Median (Min-Max) Median (Min-Max)
Presepsin (pg/ml) 
at day 1
364.90 (149.40–2640) 376.85 (228.20–2479.70) 0.430
Presepsin (pg/ml) 
at day 3
384.10 (75.90–2263.60) 376.85 (228.20–2479.70) 0.845
Presepsin levels at day 1 and day 3 of 
admission were not different between critical septic and 
healthy children (Table 2).
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Presepsin levels were correlated with the 
grade of sepsis (r = 0.346, p = 0.04). Critical patients 
were further subdivided children into two groups, the 
sepsis only group (n = 10) and the severe sepsis and 
septic shock group (n = 19). We observed that the 
median level of presepsin had a progressive increase 
in the severe sepsis, septic shock group at day 3, but 
we did not observe a similar increase in the sepsis only 
group. This increase, however, did not reach a statistical 
significance (Table 3).
antibiotic administration and consequently lead to 
increased mortality [19]; hence, the importance of early 
diagnostic markers of sepsis and proper follow up of the 
response to the therapy.
Our study showed that presepsin levels 
could not differentiate between the critically ill septic 
patients (median = 365 pg/ml) and the healthy children 
(median = 376 pg/ml) neither at day 1 nor day 3. This 
was similar to a study conducted on a cohort of pediatric 
critical patients and suggested that the presepsin could 
not differentiate between septic critical patients and 
healthy controls and thus raising doubt on its value as 
an inflammatory marker in pediatric critical illness [20].
Age-related variations in the cutoff value were 
reported. In the adult study, a cutoff value of 317 pg/ml 
was used in diagnosing sepsis [21], while in preterm 
neonates, it was 885 ng/l [22]. In a recent study, 
presepsin levels were found to be lower in neonates 
with more advanced gestational age [23]. This may 
explain why the median values of presepsin levels in 
our children were lower than neonatal studies.
A recent systematic review and meta-analysis 
in children indicated the high sensitivity and diagnostic 
accuracy of presepsin in detecting sepsis, but lower 
specificity, than procalcitonin (PCT) or CRP [12]. This 
analysis included four studies, of which three included 
pediatric hemato-oncological patients; some of them 
had chemotherapy-induced neutropenic fever.
Controversies in adult studies excited, some 
suggested that its use is associated with a relatively 
high rate of miss diagnosis and misdiagnosis and should 
instead be used in conjunction with more conventional 
tests, such as PCT, rather than replace it [24]. Others 
described it to have a moderate diagnostic capacity 
for the detection of sepsis [1], [25]. On the contrary, 
others suggested the differentiating value of presepsin 
between cases and controls [26], [27].
Neonatal studies suggested the high 
sensitivity of presepsin for the detection of sepsis in 
neonates [27], [28], [29]. Similarly, Poggi et al. detected 
the possible use for monitoring antibiotic response in 
septic neonate [22].
We detected a positive correlation between 
the grade of sepsis and presepsin level. Carpio et al. 
mentioned that presepsin levels were elevated at an early 
stage of sepsis and increased with its progression [30].
We observed that there was a significant 
statistical difference between the presepsin levels 
at day 1 in anemic versus non-anemic patients. In 
accordance with our results, Malgorzata et al. and 
Motoi et al. found that there was a significant inverse 
correlation between presepsin concentrations in septic 
newborns and hemoglobin, hematocrit value, and 
platelet counts [31], [32].
There was a significant association between 
the CRP level of the septic patients and presepsin 
Table 3: Comparison of presepsin levels at day 1 and day 3 
between two groups of patients (patients with only sepsis 
and patients with severe sepsis and septic shock as a second 
group)
Subgroup Presepsin at day 1 Presepsin at day 3 p value
Median (Min-Max) Median (Min-Max)
Sepsis (n=10) 355.70 (169.80–428.90) 345.70 (190.60–465.30) 0.188
Severe sepsis and 
septic shock (n=19)
394.50 (149.40–2640) 500.60 (75.90–2263.60) 0.084
Table 4: Comparison between presepsin at day 1 and day 3 
and clinical and laboratory parameters of patients
Clinical and 
laboratory data
Presepsin at day 1 Presepsin at day 3
Correlation coefficient p value Correlation coefficient p value
SOFA score 0.128 0.483 0.038 0.838
Grade of sepsis 0.365 0.040 0.325 0.07
PH −0.160 0.383 0.196 0.281
HCO3 0.212 0.243 0.243 0.180
Hemoglobin −0.369 0.038 −0.183 0.317
WBC count 0.001 0.998 −0.294 0.102
Platelet count −0.029 0.877 0.164 0.370
CRP 0.576 0.001 0.598 0.001
Table 5: Comparison between the presepsin at day 1 and day 3 
and the results of the cultures
Organism Presepsin at day 1 p value Presepsin at day 3 p value
Median (Min-Max) Median (Max-Min)
Fungal infection 154.30 
(154.30–154.30)
0.298 140 (140–140) 0.072
Gram-negative 
bacteria
395 (149.40–2640) 451.30 
(202.90–2263.60)
Gram-positive 
bacteria
380.10 
(302.90–1575.40)
345.20 
(75.90–839.10)
There was a significant statistical difference 
between the CRP level and hemoglobin level of 
patients and the presepsin level at day 1 but not at day 
3 (Table 4).
There was a non-significant difference between 
the presepsin level at day 1 and day 3 and the type of 
organism causing infection but it was noticed that the 
median level of the marker at day 1 and day 3 was 
highest at the Gram-negative cultures and lowest with 
the fungal infections (Table 5).
Discussion
Early recognition of sepsis, severe sepsis and 
septic shock, and speed and appropriateness of therapy 
in the initial hours after presentation considerably 
influence the outcomes of septic patients [17]. Blood 
culture usually requires several days for results to be 
known [18] and false-negative results may delay the 
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level at day 1 and day 3. This result was in agreement 
with a study on septic newborns which concluded that 
there was a positive correlation between presepsin 
concentrations and CRP in septic newborns [23]. 
Moreover, Chenevier-Gobeaux et al. and Motoi 
et al. reached similar results in a study conducted on 
adults [11], [32].
We noticed that the median levels of the 
marker at day 1 and day 3 were highest in the 
Gram-negative cultures and lowest with the fungal 
infections with a p-value only approaching statistical 
significance. Studies concluded that presepsin showed 
the highest sensitivity in predicting Gram-negative 
bacteria [33], [34], [35]. On the contrary, Topcuoglu 
et al. stated that there were no differences between 
the initial presepsin levels of patients in the late-onset 
sepsis and the type of growth in blood culture [21]. This 
result was agreed by two studies which were conducted 
on adults [32], [36].
Conclusions
This study demonstrated that presepsin is not a 
reliable marker for discrimination between the critically 
sick septic children and healthy children. However, its 
serum levels increased congruently with the severity of 
sepsis in critically sick children. Our small sample size 
is a limiting factor and further studies with larger sample 
sizes, with each group of sepsis severity, are needed.
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